VolitionRX Ltd To Present At GCFF Transcript
We are VolitionRX. Ticker is BNRX on the New York Stock Exchange, American Stock Exchange. I will be making some forward-looking statements. So I do point you to the forward-looking statements and disclaimer. And a little bit about Volition. Volition is simple. We want to save lives.
We are a diagnostics company, developing blood tests to screen primarily for different cancer types. But As Gilbert mentioned, we are also developing a blood test for a noncancer indication [of] COVID-19. And I'll talk a little bit about that product because the coronavirus is front and center for most of us these days.
So here, you can see a little bit about our COVID-19 product development, developing a blood tests for this particular virus. We are not developing a frontline blood test for the coronavirus. There are a number of FDA approved frontline screens for the coronavirus already in use in the United States.
What we are planning to develop is a triage or a risk stratification blood test to be given to patients who have had a
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |